StockData

Astrotech vs EyePoint

ASTC and EYPT side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ASTC and EYPT compare

EyePoint is the larger company, worth 3.5 times as much as Astrotech ($26.5M against $7.6M).

Astrotech grew revenue faster over the last twelve months (−13.0% versus −94.6% for EyePoint).

Astrotech keeps more of each dollar of sales as profit, with a net margin of −1580% compared with −10995% at EyePoint.

Astrotech scores higher on the StockData Score (8 against 6 for EyePoint), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricASTCEYPT
Size and price
Market cap$7.6M$26.5M
Share price$3.76$0.308
Change, 1 year14.6%−97.3%
Change, 5 years−84.5%−98.1%
Beta (5Y)–3.25
Employees28214
StockData Score
Total score8 (better)6
Valuation score3 (better)1
Growth score00
Performance score00
Health score55
Dividend score00
Valuation
P/S8.3× (better)9.5×
P/B0.5×0.2× (better)
FCF yield−190% (better)−1023%
Fair value$8.86–
Margin of safety57.5%–
Growth
Revenue growth (TTM)−13.0% (better)−94.6%
Revenue growth, 5Y average22.3% (better)−1.8%
Profitability
Gross margin23.8%–
Operating margin−1549% (better)−11365%
Net margin−1580% (better)−10995%
FCF margin−1570% (better)−9727%
Return on equity−75.4% (better)−149%
Return on invested capital−256%–
Financial health
Debt / equity0.000.00
Current ratio7.06 (better)4.50
Altman Z-score−18.50−11.42 (better)
Piotroski F-score22
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions8.6%108%
Held by insiders16.6%0.96%
Insider net buying, 12 months–−$1.9M
Short interest, % of float3.5%12.9%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.